← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

President and CEO Dennis M Lanfear sold $232K of Coherus Oncology, Inc.

Sold$231,960
$18.56Price
12,500Shares
−2%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Thu, Nov 21. Filed Mon, Nov 25, 11:03 AM ET, during the session. Not investment advice.